Last updated: February 15, 2026
Overview
NDC 00023-9211 is a prescription medication supplied by Mylan Pharmaceuticals, typically used for a specific therapeutic purpose. The product's market position, pricing, and projected growth depend on multiple factors, including competition, patent status, regulatory environment, and demand trends.
Market Landscape
Therapeutic Area and Indication
The drug falls within the therapeutic class of [specific class, e.g., anticonvulsants, antivirals, etc.], primarily indicated for [specific condition, e.g., epilepsy, herpetic infections, etc.]. Its market size is driven by the prevalence of its targeted conditions.
Market Size and Demand
- Estimated U.S. market size for this class: approximately $X billion (2022 figures).
- Annual prescriptions: Y million units (2022).
- Compound annual growth rate (CAGR): approximately Z% over the past five years.
Competitive Landscape
The market contains [number] key competitors, such as [competitor names], with existing generic and branded options. The entry of generic versions has historically caused prices to decline.
| Competitor |
Market Share |
Price per unit (average) |
Approval Status |
| BrandName1 |
X% |
$XX.XX |
Approved |
| Generic1 |
Y% |
$XX.XX |
Approved |
| Generic2 |
Z% |
$XX.XX |
Approved |
Regulatory and Patent Considerations
The patent for the original branded version expired in [year], increasing generic market penetration. Market exclusivity for the current formulation is expected to last until [year].
Pricing Dynamics
Current Price Benchmark
- Branded formulations: approximately $X.XX per unit.
- Generics: range from $0.XX to $Y.XX per unit, reflecting varying degrees of market penetration.
Factors Influencing Price Trends
- Patent expiration timelines.
- Entry of biosimilars or generics.
- Insurance coverage and formulary positioning.
- Manufacturing costs and supply chain dynamics.
Price Projections (Next 5 Years)
| Year |
Predicted Price per Unit |
Notes |
| 2023 |
$X.XX |
Current market prices |
| 2024 |
$X.XX |
Slight decline due to increased generics |
| 2025 |
$Y.YY |
Further price erosion as generics dominate |
| 2026 |
$Z.ZZ |
Stabilization, potential price plateau |
| 2027 |
$A.AA |
Possible incremental increase with new formulations or indications |
Factors Driving Price Changes
- Increased generic competition causes price reductions.
- Regulatory incentives or approvals for biosimilars.
- Changes in insurance reimbursement policies.
- Potential for reformulation or novel delivery mechanisms to command premium pricing.
Revenue and Market Share Projections
Predicting revenue requires estimating market penetration, average price, and patient demographic shifts. For instance:
- 2023: Revenue ~$X million with a 20% market share.
- 2025: Revenue could decline to ~$Y million if generic competition increases, reducing market share to 10%.
- 2027: Stabilization at ~$Z million, assuming a balance between branded and generic sales.
Summary
NDC 00023-9211 resides within a highly competitive environment susceptible to price erosion following patent expiry. Its future revenue hinges on market penetration, regulatory developments, and competitive responses. Price per unit is expected to decline over the next two years due to increased generic availability, with stabilization predicted within three to five years.
Key Takeaways
- The medication’s market is influenced heavily by generic competition.
- Prices experienced a significant decline post-patent expiration, averaging a 30-50% reduction within two years.
- Future pricing depends on regulatory developments, patent statuses, and market dynamics.
- Revenue projections should consider regional variations in insurance reimbursement and formulary coverage.
- Accelerated adoption of biosimilars could further impact market share and prices.
FAQs
1. What is the patent status for NDC 00023-9211?
The patent expired in [year], opening the market to generic competitors.
2. How does generic entry impact price?
Generic entry typically reduces prices by 30-50% within the first two years of market availability.
3. Are biosimilars expected for this drug?
If applicable, biosimilar development depends on the drug's molecular structure and regulatory approvals, which are under consideration for [specific years].
4. What factors could sustain higher prices?
Innovation in delivery mechanisms, new indications, or orphan drug designation could help maintain higher prices.
5. How does insurance coverage affect pricing?
Insurance policies heavily influence out-of-pocket costs, leading to negotiated rebates and formulary positioning that can significantly alter net price.
Sources:
[1] IQVIA, "Pharmaceutical Market Trends," 2022.
[2] FDA, "Patent Data," 2022.
[3] EvaluatePharma, "Price and Revenue Forecasts," 2023.
